Kozovska M, Zang Y C, Aebischer I, Lnu S, Rivera V M, Crowe P D, Boehme S A, Zhang J Z
Department of Neurology and Baylor/Methodist International Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.
Eur J Immunol. 1998 Jun;28(6):1894-901. doi: 10.1002/(SICI)1521-4141(199806)28:06<1894::AID-IMMU1894>3.0.CO;2-W.
Myelin basic protein (MBP)-reactive T cells may play an important role in the pathogenesis of multiple sclerosis (MS). The T cell response to the 83-99 region of MBP represents a dominant autoreactive response to MBP in MS patients of DR2 haplotype. In this study, a large panel of DR2- and DR4-restricted T cell clones specific for the MBP83-99 peptide were examined for the recognition motifs and structural requirements for antigen recognition using alanine-substituted peptides. Our study revealed that although the recognition motifs of the T cell clones were diverse, the TCR contact residues within the 83-99 region of MBP were highly conserved. Two central residues (Phe90 and Lys91) served as the critical TCR contact points for both DR2- and DR4-restricted T cell clones. Single alanine substitution at residue 90 or residue 91 abolished the responses of 81-95 % of the T cell clones while a double alanine substitution rendered all T cell clones unresponsive. It was also demonstrated in this study that the substituted peptides altered the cytokine profile of some, but not all, T cell clones. Some MBP83-99-specific T cell clones were able to sustain alanine substitutions and were susceptible to activation by microbial antigens. The study has an important implication in designing a peptide-based therapy for MS.
髓鞘碱性蛋白(MBP)反应性T细胞可能在多发性硬化症(MS)的发病机制中起重要作用。T细胞对MBP 83-99区域的反应代表了DR2单倍型MS患者对MBP的主要自身反应。在本研究中,使用丙氨酸取代肽对一大组针对MBP83-99肽的DR2和DR4限制性T细胞克隆进行了抗原识别基序和结构要求的检测。我们的研究表明,尽管T细胞克隆的识别基序各不相同,但MBP 83-99区域内的TCR接触残基高度保守。两个中心残基(Phe90和Lys91)是DR2和DR4限制性T细胞克隆关键的TCR接触点。在第90位或第91位残基处进行单个丙氨酸取代可消除81-95%的T细胞克隆的反应,而双丙氨酸取代则使所有T细胞克隆无反应。本研究还表明,取代肽改变了部分(而非全部)T细胞克隆的细胞因子谱。一些MBP83-99特异性T细胞克隆能够耐受丙氨酸取代,并且易被微生物抗原激活。该研究对设计基于肽的MS治疗方法具有重要意义。